A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region

Annals of Epidemiology

Volumn 15, Issue 5, 2005, Pages 405-413

  Barzi, Federica ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Asia Pacific; Cardiovascular Heart Disease; HDL Cholesterol; LDL Cholesterol; Lipid Ratios; Non HDL Cholesterol; Total Cholesterol; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ASIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; STATISTICAL MODEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 17444404563     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2005.01.005     Document Type: Article

References (34)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
2. J.E. Hokanson, and M.A. Austin Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies J Cardiovasc Risk 3 1996 213 219
3. C.M. Ballantyne, and R.C. Hoogeveen Role of lipid and lipoprotein profiles in risk assessment and therapy Am Heart J 146 2003 227 233
4. Y. Cui, R.S. Blumenthal, J.A. Flaws, M.K. Whiteman, P. Langenberg, and P.S. Bachorik Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality Arch Intern Med 161 2001 1413 1419
5. B. Kinosian, H. Glick, and G. Garland Cholesterol and coronary heart disease: Predicting risks by levels and ratios Ann Intern Med 121 1994 641 647
6. W.B. Kannel, and P.W. Wilson Efficacy of lipid profiles in prediction of coronary disease Am Heart J 124 1992 768 774
7. S. Natarajan, H. Glick, M. Criqui, D. Horowitz, S.R. Lipsitz, and B. Kinosian Cholesterol measures to identify and treat individuals at risk for coronary heart disease Am J Prev Med 25 2003 50 57
8. S.A. Grover, C.S. Palmer, and L. Coupal Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort Arch Intern Med 154 1994 679 684
9. H. Buchwald, J.R. Boen, P.A. Nguyen, S.E. Williams, and J.P. Matts Plasma lipids and cardiovascular risk: A POSCH report. Program on the Surgical Control of the Hyperlipidemias Atherosclerosis 154 2001 221 227
10. H.F. Abdul-Rahim, A. Husseini, E. Bjertness, R. Giacaman, N.H. Gordon, and J. Jervell The metabolic syndrome in the West Bank population: An urban-rural comparison Diabetes Care 24 2001 275 279
11. R. Clarke, M. Shipley, S. Lewington, L. Youngman, R. Collins, and M. Marmot Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies Am J Epidemiol 150 1999 341 353
12. S. MacMahon, R. Peto, J. Cutler, R. Collins, P. Sorlie, and J. Neaton Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias Lancet 335 1990 765 774
13. Asia Pacific Cohort Studies Collaboration Determinants of cardiovascular disease in the Asia Pacific region: Protocol for a collaborative overview of cohort studies CVD Prevention 2 1999 281 289
14. Asia Pacific Cohort Studies Collaboration Cholesterol, coronary heart disease, and stroke in the Asia Pacific region Int J Epidemiol 32 2003 563 572
15. Asia Pacific Cohort Studies Collaboration Serum triglycerides as a risk factor for cardiovascular diseases in the Asia Pacific region Circulation 110 2004 2678 2686
16. W.T. Friedewald, J. Levy, and D.S. Fredrickson Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge Clin Chem 18 1972 499 509
17. D.F. Easton, J. Peto, and A.G. Babiker Floating absolute risk: An alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group Stat Med 10 1991 1025 1035
18. B. Rosner, D. Spiegelman, and W. Willet Correction of logistic regression relative risk estimates and confidence intervals for measurement error: The case of multiple covariates measured with error Am J Epidemiol 132 1990 734 745
19. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, and British Diabetic Association Joint British recommendations on prevention of coronary heart disease in clinical practice: summary BMJ 320 2000 705 708
20. K.M. Anderson, P.W. Wilson, P.M. Odell, and W.B. Kannel An updated coronary risk profile. A statement for health professionals Circulation 83 1991 356 362
21. West of Scotland Coronary Prevention Study Group Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS) Circulation 97 1998 1440 1445
22. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomized placebo-controlled trial Lancet 360 2002 7 22
23. J. Simes, C.D. Furberg, E. Braunwald, B.R. Davis, I. Ford, and A. Tonkin Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project Eur Heart J 23 1997 207 215
24. S.A. Grover, L. Coupal, and X.P. Hu Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work? JAMA 274 1995 801 806
25. B. Kinosian, H. Glick, L. Preiss, and K.L. Puder Cholesterol and coronary heart disease: Predicting risks in men by changes in levels and ratios J Invest Med 43 1995 443 450
26. J.M. Gaziano, C.H. Hennekens, C.J. O'Donnell, J.L. Breslow, and J.E. Buring Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction Circulation 96 1997 2520 2525
27. P.H. Frost, and R.J. Havel Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy Am J Cardiol 81 1998 26B 31B
28. Y. He, T.H. Lam, L.S. Li, L.S. Li, S.F. He, and X.Q. Liang Triglyceride and coronary heart disease mortality in a 24-year follow-up study in Xi'an, China Ann Epidemiol 14 2004 1 7
29. BIP Study Group Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: The Bezafibrate Infarction Prevention (BIP) study Circulation 102 2000 21 27
30. V. Manninen, L. Tenkanen, P. Koskinen, J.K. Huttunen, M. Manttari, and O.P. Heinonen Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment Circulation 85 1992 37 45
31. S. Robins, D. Collins, J. Wittes, V. Papademetriou, P. Deedwania, and E.J. Schaefer Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT - a randomized controlled trial JAMA 285 2001 1585 1591
32. H.B. Rubins, S.J. Robins, D. Collins, C.L. Fye, J.W. Anderson, and M.B. Elam Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-density Lipoprotein Cholesterol Intervention Trial Study Group N Engl J Med 341 1999 410 418
33. H.W. Peters, I.C. Westendorp, A.E. Hak, D.E. Grobbee, C.D. Stehouwer, and A. Hofman Menopausal status and risk factors for cardiovascular disease J Intern Med 246 1999 521 528
34. P.L. Toring, T.C. Su, F.C. Sung, K.L. Chien, S.C. Huang, and S.N. Chow Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight - The Chin-Shan Community Cardiovascular Cohort Study Atherosclerosis 161 2002 409 415